Welcome

Medasense Biometrics is a medical device company that develops a continuous and non-invasive pain-monitoring device.

The Business Opportunity

The assessment of a patient’s pain level is critical to ensure the effectiveness of on-going care. Various studies suggest that using valid and reliable pain-monitoring systems can minimize the use of sedative and analgesic drugs; decrease the patient’s recovery time, lessen the risk of side effects, and reduce direct and indirect costs. Currently, pain level is monitored based on the patient’s subjective statement, if the patient can communicate, or based on physician’s estimation, if the patient cannot communicate.

The Technology

Medasense develops a pain-monitoring system, an innovative, patent-pending platform technology for automated and continuous assessment of a patient’s pain level. Medasense’s solution is based on a non-invasive acquisition of multiple patients’ physiological signals.

 

News

September, 2011:
Medasense Biometrics chosen to present at the 8th Annual Israel Strategic Partner and Venture Conference on September 22, 2011

September, 2011:
Results of Medasense supported research were presented at "Pain in Europe VII", the 7th Congress of the European Federation of International Association for the Study of Pain Chapters

August, 2011:
Medasense Biometrics technology is featured in a newspaper article “Feel its pain: why the healthcare system doesn’t have a standard for measuring pain?” by Gali Weinreb, Globes, August 27th, 2011

June, 2011:
Medasense Biometrics has appeared on "The Landes Shortlist of Promising Israeli Technologies", by C. Wylie, Cell Cycle, Vol. 10, pp. 1887-1881.

May 2011:
Medasense to present at ILSI- Biomed Israel 2011 (Monday, May 23, 18:10 – 18:30)

December 2010:
OHV and Dr. Shmuel Cabilly invest in Medasense Biometrics

November 2010:
Results of Medasense supported research were presented on the annual conference of the Israel Pain Association

June 2010:
Medasense to present at Personalized Medicine World Conference 2010 Israel

December 2008:
Capital Point invests in Medasense Biometrics